IL33 and atopic eczema: There is an especially close link between IL-33 and atopic dermatitis: while efficacy of anti-IL-33-tageted therapies is still not completely defined, etokimab (a therapeutic anti-IL-33 antibody) showed improvement in skin score and reduced skin neutrophil infiltration after a single administration [104,105].